Ibrahim H. Eissa

7.7k citations

206 papers · 6.6k · 1 hit paper · h-index 52

Impact in

Toxicology top 0.05%
- Bioactive Compounds and Antitumor Agents
Organic Chemistry top 0.2%
- Synthesis and biological activity
- Synthesis and Biological Evaluation
- Quinazolinone synthesis and applications
- Click Chemistry and Applications

Papers in

Organic Chemistry 123
- Synthesis and biological activity 89
- Synthesis and Biological Evaluation 34
- Quinazolinone synthesis and applications 26
Molecular Biology 115
- Angiogenesis and VEGF in Cancer 39
- Cancer therapeutics and mechanisms 36

Co-authors: Ahmed M. Metwaly (137 shared papers)Eslam B. Elkaeed (123 shared papers)Hazem Elkady (81 shared papers)Khaled El‐Adl (23 shared papers)Ahmed B. M. Mehany (24 shared papers)Hazem A. Mahdy (32 shared papers)Aisha A. Alsfouk (55 shared papers)Ahmed A. Al‐Karmalawy (9 shared papers)
Journals: Bioorganic Chemistry (17 papers)Molecules (16 papers)Journal of Enzyme Inhibition and Medicinal Chemistry (15 papers)Archiv der Pharmazie (14 papers)RSC Advances (12 papers)
Partner nations: Egypt Saudi Arabia United States

In The Last Decade

Ibrahim H. Eissa

197 papers receiving 6.6k citations

Hit Papers

align trajectories log scale

Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor 2021 · 209 citations

Peers

Countries citing papers authored by Ibrahim H. Eissa

Since Specialization

Citations

This map shows the geographic impact of Ibrahim H. Eissa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ibrahim H. Eissa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ibrahim H. Eissa more than expected).

Fields of papers citing papers by Ibrahim H. Eissa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ibrahim H. Eissa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ibrahim H. Eissa. The network helps show where Ibrahim H. Eissa may publish in the future.

Co-authors

The 25 scholars most cited alongside Ibrahim H. Eissa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ibrahim H. Eissa Line = papers co-authored together Ibrahim H. Eissa links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 206 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor Frontiers in Chemistry ·Ahmed A. Al‐Karmalawy, Mohammed A. Dahab, Ahmed M. Metwaly, Sameh S. Elhady, Eslam B. Elkaeed, Ibrahim H. Eissa, Khaled M. Darwish Hit paper breakdown →	2021	209
2	Design, synthesis and anticancer evaluation of thieno[2,3-d]pyrimidine derivatives as dual EGFR/HER2 inhibitors and apoptosis inducers Bioorganic Chemistry ·Souad A. El‐Metwally, Khaled F. Saied, Ibrahim H. Eissa, Eslam B. Elkaeed	2019	157
3	Design, synthesis, molecular modeling, in vivo studies and anticancer evaluation of quinazolin-4(3H)-one derivatives as potential VEGFR-2 inhibitors and apoptosis inducers Bioorganic Chemistry ·Hazem A. Mahdy, M.K. Ibrahim, Ahmed M. Metwaly, Amany Belal, Ahmed B. M. Mehany, Kamal M. El‐Gamal, Abdou El-Sharkawy, Mostafa A. Elhendawy, Mohamed M. Radwan, Mahmoud A. ElSohly, Ibrahim H. Eissa	2019	152
4	Design, synthesis, molecular docking, and anticancer activity of benzoxazole derivatives as VEGFR‐2 inhibitors Archiv der Pharmazie ·Abdel‐Ghany A. El‐Helby, Helmy Sakr, Ibrahim H. Eissa, Hamada S. Abulkhair, Ahmed A. Al‐Karmalawy, Khaled El‐Adl	2019	140
5	Novel 4/3-((4-oxo-5-(2-oxoindolin-3-ylidene)thiazolidin-2-ylidene)amino) benzenesulfonamides: Synthesis, carbonic anhydrase inhibitory activity, anticancer activity and molecular modelling studies European Journal of Medicinal Chemistry ·Wagdy M. Eldehna, Mahmoud F. Abo-Ashour, Alessio Nocentini, Paola Gratteri, Ibrahim H. Eissa, Mohamed Farès, Omnia E. Ismael, Hazem A. Ghabbour, Mahmoud M. Elaasser, Hatem A. Abdel‐Aziz, Claudiu T. Supuran	2017	130
6	Design, synthesis, molecular modeling and biological evaluation of novel 1H-pyrazolo[3,4-b]pyridine derivatives as potential anticancer agents Bioorganic Chemistry ·Ibrahim H. Eissa, Abeer M. El‐Naggar, Maher A. El‐Hashash	2016	122
7	Design, synthesis and anticancer evaluation of 1H-pyrazolo[3,4-d]pyrimidine derivatives as potent EGFRWT and EGFRT790M inhibitors and apoptosis inducers Bioorganic Chemistry ·Ahmed A. Abdel Gaber, Ashraf H. Bayoumi, Ahmed El-morsy, Farag F. Sherbiny, Ahmed B. M. Mehany, Ibrahim H. Eissa	2018	122
8	New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studies Journal of Enzyme Inhibition and Medicinal Chemistry ·Hazem Elkady, Alaa Elwan, Hesham A. El‐Mahdy, Ahmed S. Doghish, Ahmed Ismail, Mohammed S. Taghour, Eslam B. Elkaeed, Ibrahim H. Eissa, Mohammed A. Dahab, Hazem A. Mahdy, Mohamed M. Khalifa	2021	112
9	Design, synthesis, molecular modeling and anti-proliferative evaluation of novel quinoxaline derivatives as potential DNA intercalators and topoisomerase II inhibitors European Journal of Medicinal Chemistry ·M.K. Ibrahim, Mohammed S. Taghour, Ahmed M. Metwaly, Amany Belal, Ahmed B. M. Mehany, Mostafa A. Elhendawy, Mohamed M. Radwan, Abdelrahman M. Yassin, Nehal M. El‐Deeb, E. S. E. Hafez, Mahmoud A. ElSohly, Ibrahim H. Eissa	2018	109
10	Traditional ancient Egyptian medicine: A review Saudi Journal of Biological Sciences ·Ahmed M. Metwaly, Mohammed M. Ghoneim, Ibrahim H. Eissa, Islam A. Elsehemy, Ahmad E. Mostafa, Mostafa M. Hegazy, Wael M. Afifi, Deqiang Dou	2021	105
11	Discovery of thieno[2,3-d]pyrimidine-based derivatives as potent VEGFR-2 kinase inhibitors and anti-cancer agents Bioorganic Chemistry ·Souad A. El‐Metwally, Mohsen M. Abou-El-Regal, Ibrahim H. Eissa, Ahmed B. M. Mehany, Hazem A. Mahdy, Hazem Elkady, Alaa Elwan, Eslam B. Elkaeed	2021	104
12	Discovery of new pyrimidine-5-carbonitrile derivatives as anticancer agents targeting EGFR^WTand EGFR^T790M Organic & Biomolecular Chemistry ·Ahmed Abdel Nasser, Ibrahim H. Eissa, Mohamed R. Oun, Mohamed Ayman El‐Zahabi, Mohammed S. Taghour, Amany Belal, Abdulrahman M. Saleh, Ahmed B. M. Mehany, Hendrik Luesch, Ahmad E. Mostafa, Wael M. Afifi, James R. Rocca, Hazem A. Mahdy	2020	103
13	Benzoxazole/benzothiazole‐derived VEGFR‐2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluations Archiv der Pharmazie ·Abdel‐Ghany A. El‐Helby, Helmy Sakr, Ibrahim H. Eissa, Ahmed A. Al‐Karmalawy, Khaled El‐Adl	2019	103
14	Design, Synthesis, Docking, DFT, MD Simulation Studies of a New Nicotinamide-Based Derivative: In Vitro Anticancer and VEGFR-2 Inhibitory Effects Molecules ·Eslam B. Elkaeed, Reda G. Yousef, Hazem Elkady, Ibraheem M. M. Gobaara, Bshra A. Alsfouk, Dalal Z. Husein, Ibrahim M. Ibrahim, Ahmed M. Metwaly, Ibrahim H. Eissa	2022	94
15	Discovery of new quinoxaline-2(1H)-one-based anticancer agents targeting VEGFR-2 as inhibitors: Design, synthesis, and anti-proliferative evaluation Bioorganic Chemistry ·Khaled El‐Adl, Helmy Sakr, Reda G. Yousef, Ahmed B. M. Mehany, Ahmed M. Metwaly, Mostafa A. Elhendawy, Mohamed M. Radwan, Mahmoud A. ElSohly, Hamada S. Abulkhair, Ibrahim H. Eissa	2021	93
16	Design, synthesis, molecular docking and anticancer evaluations of 5-benzylidenethiazolidine-2,4-dione derivatives targeting VEGFR-2 enzyme Bioorganic Chemistry ·Khaled El‐Adl, Abdel‐Ghany A. El‐Helby, Helmy Sakr, Ibrahim H. Eissa, Sanadelaslam S. A. El‐Hddad, Fatma M.I.A. Shoman	2020	91
17	Design, synthesis, and biological evaluation of new challenging thalidomide analogs as potential anticancer immunomodulatory agents Bioorganic Chemistry ·Mohamed Ayman El‐Zahabi, Helmy Sakr, Khaled El‐Adl, Mohamed F. Zayed, Adel S. Abdelraheem, Sally I. Eissa, Hazem Elkady, Ibrahim H. Eissa	2020	91
18	New bis([1,2,4]triazolo)[4,3-a:3′,4′-c]quinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, in silico studies, and anticancer evaluation Bioorganic Chemistry ·Mohammed M. Alanazi, Hazem A. Mahdy, Nawaf A. Alsaif, Ahmad J. Obaidullah, Hamad M. Alkahtani, Abdulrahman A. Almehizia, Sultan M. Alsubaie, Mohammed A. Dahab, Ibrahim H. Eissa	2021	88
19	Design and synthesis of thiazolidine-2,4-diones hybrids with 1,2-dihydroquinolones and 2-oxindoles as potential VEGFR-2 inhibitors: in-vitro anticancer evaluation and in-silico studies Journal of Enzyme Inhibition and Medicinal Chemistry ·Mohammed S. Taghour, Hazem Elkady, Wagdy M. Eldehna, Nehal M. El‐Deeb, Ahmed M. Kenawy, Eslam B. Elkaeed, Aisha A. Alsfouk, Mohamed S. Alesawy, Ahmed M. Metwaly, Ibrahim H. Eissa	2022	86
20	Design, synthesis, and anti-proliferative evaluation of new quinazolin-4(3H)-ones as potential VEGFR-2 inhibitors Bioorganic & Medicinal Chemistry ·Khaled El‐Adl, Abdel‐Ghany A. El‐Helby, Rezk R. Ayyad, Hazem A. Mahdy, Mohamed M. Khalifa, H. El-Nagar, Ahmed B. M. Mehany, Ahmed M. Metwaly, Mostafa A. Elhendawy, Mohamed M. Radwan, Mahmoud A. ElSohly, Ibrahim H. Eissa	2020	85

About Ibrahim H. Eissa

Ibrahim H. Eissa is a scholar working on Organic Chemistry, Molecular Biology, Toxicology, Computational Theory and Mathematics and Oncology, having authored 206 papers that have together received 6.6k indexed citations. Recurring topics across this work include Synthesis and biological activity (89 papers), Bioactive Compounds and Antitumor Agents (43 papers), Computational Drug Discovery Methods (40 papers), Angiogenesis and VEGF in Cancer (39 papers), Cancer therapeutics and mechanisms (36 papers), Synthesis and Biological Evaluation (34 papers), Quinazolinone synthesis and applications (26 papers) and Cancer Mechanisms and Therapy (24 papers). The work is most often cited by research in Toxicology (1.0k citations), Organic Chemistry (4.2k citations), Computational Theory and Mathematics (1.1k citations), Molecular Biology (3.2k citations) and Oncology (1.0k citations). Ibrahim H. Eissa has collaborated with scholars based in Egypt, Saudi Arabia and United States. Frequent co-authors include Ahmed M. Metwaly, Eslam B. Elkaeed, Hazem Elkady, Khaled El‐Adl, Ahmed B. M. Mehany, Hazem A. Mahdy, Aisha A. Alsfouk, Ahmed A. Al‐Karmalawy, Mohammed S. Taghour and Helmy Sakr. Their work appears in journals such as Bioorganic Chemistry, Molecules, Journal of Enzyme Inhibition and Medicinal Chemistry, Archiv der Pharmazie and RSC Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Ibrahim H. Eissa

Impact in

Papers in i

In The Last Decade

Ibrahim H. Eissa

Hit Papers

Peers

Countries citing papers authored by Ibrahim H. Eissa

Fields of papers citing papers by Ibrahim H. Eissa

All Works

About Ibrahim H. Eissa

Explore authors with similar magnitude of impact

Papers in